Sustained Improvement in Clinical Efficacy, Asthma Control, and Quality of Life in Patients With Severe, Oral Corticosteroid (OCS)-Dependent Asthma Treated With Dupilumab : LIBERTY ASTHMA TRAVERSE Study
| dc.contributor.author | Gurnell, Mark | |
| dc.contributor.author | Domingo, Christian | |
| dc.contributor.author | Rabe, Klaus F | |
| dc.contributor.author | Menzies-Gow, Andrew | |
| dc.contributor.author | Price, David | |
| dc.contributor.author | Brusselle, Guy | |
| dc.contributor.author | Wechsler, Michael E | |
| dc.contributor.author | Xia, Changming | |
| dc.contributor.author | Pandit-Abid, Nami | |
| dc.contributor.author | Gall, Rebecca | |
| dc.contributor.author | Jacob-Nara, Juby A. | |
| dc.contributor.author | Rowe, Paul J. | |
| dc.contributor.author | Deniz, Yamo | |
| dc.contributor.author | Siddiqui, Shahid | |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2023-06-30T23:13:11Z | |
| dc.date.available | 2023-06-30T23:13:11Z | |
| dc.date.embargoedUntil | 2023-07-01 | |
| dc.date.issued | 2023 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 1 | |
| dc.format.extent | 179437 | |
| dc.identifier | 291712889 | |
| dc.identifier | 4a06b9d2-79d7-4f18-85da-7b754d01ee24 | |
| dc.identifier.citation | Gurnell, M, Domingo, C, Rabe, K F, Menzies-Gow, A, Price, D, Brusselle, G, Wechsler, M E, Xia, C, Pandit-Abid, N, Gall, R, Jacob-Nara, J A, Rowe, P J, Deniz, Y & Siddiqui, S 2023, 'Sustained Improvement in Clinical Efficacy, Asthma Control, and Quality of Life in Patients With Severe, Oral Corticosteroid (OCS)-Dependent Asthma Treated With Dupilumab : LIBERTY ASTHMA TRAVERSE Study', Allergy: European Journal of Allergy and Clinical Immunology, vol. 78, no. S111, 001590, pp. 237. https://doi.org/10.1111/all.15616 | en |
| dc.identifier.doi | 10.1111/all.15616 | |
| dc.identifier.issn | 0105-4538 | |
| dc.identifier.uri | https://hdl.handle.net/2164/21074 | |
| dc.identifier.vol | 78 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Allergy: European Journal of Allergy and Clinical Immunology | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | Sustained Improvement in Clinical Efficacy, Asthma Control, and Quality of Life in Patients With Severe, Oral Corticosteroid (OCS)-Dependent Asthma Treated With Dupilumab : LIBERTY ASTHMA TRAVERSE Study | en |
| dc.type | Journal item | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Gurnell_etal_EAACI_Sustained_Improvement_In_AAM.pdf
- Size:
- 175.23 KB
- Format:
- Adobe Portable Document Format
